Seasoned entrepreneur and investor focused on European SaaS and fintech companies, combining hands-on operating experience with early-stage investing and board-level oversight. Szymon Ozog has founded and scaled technology businesses, advises startup leadership on product and go-to-market strategy, and participates in seed to Series B financings. Market-oriented, operational skill set supports portfolio companies on hiring, growth metrics and capital formation.
Seasoned entrepreneur and investor focused on European SaaS and fintech companies, combining hands-on operating experience with early-stage investing and board-level oversight. Szymon Ozog has founded and scaled technology businesses, advises startup leadership on product and go-to-market strategy, and participates in seed to Series B financings. Market-oriented, operational skill set supports portfolio companies on hiring, growth metrics and capital formation.
Early-stage, founder-friendly investing that prioritizes European SaaS and fintech businesses with clear product-market fit and scalable go-to-market motion. Capital allocation favors seed through Series B tickets, mixing pre-seed conviction bets with follow-on reserves to protect ownership into value-creating inflection points. Time horizon is growth-oriented, patient but outcomes-driven; decisions weight unit economics, retention metrics, and founder-market alignment. Risk discipline emphasizes thesis-driven concentrations, active board or advisory roles to de-risk execution, and rapid operational support on hiring, product strategy and go-to-market to accelerate tranche-based value realization.
Early-stage, founder-friendly investing that prioritizes European SaaS and fintech businesses with clear product-market fit and scalable go-to-market motion. Capital allocation favors seed through Series B tickets, mixing pre-seed conviction bets with follow-on reserves to protect ownership into value-creating inflection points. Time horizon is growth-oriented, patient but outcomes-driven; decisions weight unit economics, retention metrics, and founder-market alignment. Risk discipline emphasizes thesis-driven concentrations, active board or advisory roles to de-risk execution, and rapid operational support on hiring, product strategy and go-to-market to accelerate tranche-based value realization.
| Trades 624 | Longs Won 362/624 58% | Profit Factor 2.68 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7.37M |
| Average Win $2.88M | Best Trade (Oct 14) $104.94M | Sharpe Ratio -8.67 |
| Average Loss -$1.49M | Worst Trade (Dec 30) -$42M | Z-Score -1.44 (85.35%) |
| Commissions $0 | Avg. Trade Length 11m 3w 6d | Expectancy $1.05M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.09% |
| Consecutive Losing Trades | 1,161 | 1,045 | 929 | 813 | 697 | 581 | 465 | 348 | 232 | 116 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 41,662 | $10.43M | $14.29M | - | $3.86M | 36.99% | -0.006% |
ABVX Abivax SA ADR | 765,332 | $66.93M | $70.31M | - | $3.38M | 5.05% | +4.421% |
ALB Albemarle Corporation | 407,798 | $55.06M | $39.64M | - | -$15.43M | -28.02% | -0.786% |
AMAT Applied Materials, Inc. | 80,404 | $15.93M | $34.31M | - | $18.39M | 115.44% | -4.451% |
AMD Advanced Micro Devices, Inc. | 208,567 | $106.55M | $114.23M | - | $7.69M | 7.21% | -4.049% |
AMZN Amazon.com Inc | 414,360 | $95.23M | $104.88M | - | $9.65M | 10.13% | -0.382% |
AVGO Broadcom Inc. | 141,283 | $41.06M | $47.98M | - | $6.92M | 16.86% | -1.918% |
BAC Bank of America Corporation | 7,522 | $413,710 | $385,765.77 | - | -$27,944.23 | -6.75% | -0.204% |
CAT Caterpillar Inc. | 3,093 | $1.77M | $2.26M | - | $486,265.97 | 27.44% | -2.523% |
CEG Constellation Energy Corporation | 204,196 | $53.87M | $55.47M | - | $1.6M | 2.97% | -2.822% |
CRM Salesforce Inc | 9,183 | $3.07M | $2.26M | - | -$814,761.63 | -26.54% | +4.092% |
CRWD CrowdStrike Holdings, Inc. | 402,648 | $45.9M | $97.34M | - | $51.44M | 112.07% | -3.025% |
CVX Chevron Corporation | 6,688 | $1.38M | $1.48M | - | $93,899.5 | 6.79% | -0.495% |
CYTK Cytokinetics, Incorporated | 660,310 | $24.23M | $42.38M | - | $18.15M | 74.93% | +1.182% |
FCX Freeport-McMoRan Inc. | 555,093 | $7.28M | $38.56M | - | $31.28M | 429.88% | -0.223% |
GEV GE Vernova Inc. | 5,795 | $4.61M | $5.3M | - | $690,872.29 | 14.99% | -2.865% |
GOOG Alphabet Inc | 120,067 | $34.98M | $41.44M | - | $6.46M | 18.47% | +0.436% |
GOOGL Alphabet Inc | 101,014 | $31.97M | $35.28M | - | $3.31M | 10.35% | +0.457% |
GS The Goldman Sachs Group, Inc. | 1,289 | $1.09M | $1.13M | - | $42,077.47 | 3.86% | +0.019% |
HQY HealthEquity Inc. | 456,922 | $38.66M | $42.18M | - | $3.52M | 9.11% | +2.726% |